Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4501 AL 4515

Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease

Deardorff WJ, Grossberg GT.

Expert Opin Pharmacother. 2016 Sep;17(13):1789-800. doi: 10.1080/14656566.2016.1215431. Epub 2016 Jul 29.

Potential Therapeutic Effects of Oleuropein Aglycone in Alzheimer's Disease

Martorell M, Forman K, Castro N, Capó X, Tejada S, Sureda A.

Curr Pharm Biotechnol. 2016;17(11):994-1001. doi: 10.2174/1389201017666160725120656.

Old and new acetylcholinesterase inhibitors for Alzheimer's disease

Galimberti D, Scarpini E.

Expert Opin Investig Drugs. 2016 Oct;25(10):1181-7. doi: 10.1080/13543784.2016.1216972. Epub 2016 Aug 5.

[Progress of clinical trials in Alzheimer’s disease drugs]

Peng Y, Li PP, Li L, Zhang Y, Hou WZ, Cui DD, Li J, Wang L, Wang QL, Wang XL.

Yao Xue Xue Bao. 2016 Aug;51(8):1185-95.

Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer's Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A New/Old Potential Target

Arosio B, Casati M, Gussago C, Ferri E, Abbate C, Scortichini V, Colombo E, Rossi PD, Mari D.

J Alzheimers Dis. 2016 Sep 6;54(2):417-25. doi: 10.3233/JAD-160324.

Editorial (Thematic Issue: Old Facts and New Perspectives to Face Alzheimer's Dementia. Focus on Non Neuronal Participants to Neurodegeneration)

Martorana A, Silvestrini M.

CNS Neurol Disord Drug Targets. 2016;15(6):646. doi: 10.2174/1871527315999160606154409.

Treatment strategies in Alzheimer's disease: a review with focus on selenium supplementation

Aaseth J, Alexander J, Bjørklund G, Hestad K, Dusek P, Roos PM, Alehagen U.

Biometals. 2016 Oct;29(5):827-39. doi: 10.1007/s10534-016-9959-8. Epub 2016 Aug 16.

Editorial (Thematic Issue: Current and Perspective Therapeutic Strategies for Alzheimer's Disease)

Piccionello AP, Cappello F.

Curr Pharm Des. 2016;22(26):3935-6. doi: 10.2174/138161282226160801224800.

The Anti-Inflammatory Role of Minocycline in Alzheimer´s Disease

Budni J, Garcez ML, de Medeiros J, Cassaro E, Bellettini-Santos T, Mina F, Quevedo J.

Curr Alzheimer Res. 2016;13(12):1319-1329. doi: 10.2174/1567205013666160819124206.

Editorial: Combining Forces to Improve Alzheimer's Disease Drug Discovery: The Symptomatic Battle

Deguil J, Auffret A, Schenker E, Aujard F, Lamberty Y, Bartrès-Faz D, Blin O, Micallef J, Richardson JC, Bordet R.

CNS Neurol Disord Drug Targets. 2016;15(7):754-5. doi: 10.2174/187152731507160808200737.

Perspectives for treating Alzheimer's disease: a review on promising pharmacological substances

Cazarim Mde S, Moriguti JC, Ogunjimi AT, Pereira LR.

Sao Paulo Med J. 2016 Jul-Aug;134(4):342-54. doi: 10.1590/1516-3180.2015.01980112.

Neuroprotective properties of mitochondria-targeted antioxidants of the SkQ-type

Isaev NK, Stelmashook EV, Genrikhs EE, Korshunova GA, Sumbatyan NV, Kapkaeva MR, Skulachev VP.

Rev Neurosci. 2016 Dec 1;27(8):849-855. doi: 10.1515/revneuro-2016-0036.

Impact of 2, 3, 5, 4'-tetrahydroxystilbene-2-O-β-D-glucoside on cognitive deficits in animal models of Alzheimer's disease: a systematic review

Sheng C, Peng W, Chen Z, Cao Y, Gong W, Xia ZA, Wang Y, Su N, Wang Z.

BMC Complement Altern Med. 2016 Aug 26;16(1):320. doi: 10.1186/s12906-016-1313-8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias